Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1Phase 1 1

Status

Recruiting 5Withdrawn 3Terminated 3Completed 3Active not recruiting 3Unknown 2

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Other hematologic neoplasm 1Gastrointestinal 1

Conditions

Neoplasms 1Liver Neoplasms 1Hematologic Neoplasms 1Hematologic Diseases 1Carcinoma, Hepatocellular 1

Interventions

pembrolizumab 437Carboplatin 322Nivolumab 292Cyclophosphamide 281Specimen Handling 271Magnetic Resonance Spectroscopy 257Cisplatin 253Paclitaxel 248Radiotherapy 229Gemcitabine 183Biopsy 182Dexamethasone 181durvalumab 168atezolizumab 151Rituximab 138Doxorubicin 135Lenalidomide 134Bevacizumab 133Docetaxel 131Ipilimumab 129Capecitabine 120Radiation 118Oxaliplatin 114Radiosurgery 113Pemetrexed 112Etoposide 111Fluorouracil 110venetoclax 106fludarabine 106Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Cell- and Tissue-Based Therapy × Clear all
NCT06084884 2026-05-22

ATHENA

AstraZeneca

Phase 1/2 Active not recruiting
94 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT06849921 2025-02-27

Precise Design of Cell Therapy for Relapsed and Refractory Hematological Tumors

Ruijin Hospital

Phase NA Active not recruiting
200 enrolled
Other hematologic neoplasm

Hematologic Diseases, Hematologic Neoplasms

NCT02193503 2023-09-28

MVX-ONCO-1 in Patients With Solid Tumor

Maxivax SA

Phase 1 Active not recruiting
34 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡